In8bio Inc Net Income
| INAB Stock | USD 1.78 0.07 3.78% |
As of the 15th of February 2026, In8bio owns the Semi Deviation of 4.8, market risk adjusted performance of 0.1479, and Standard Deviation of 6.89. In8bio Inc technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
In8bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing In8bio's valuation are provided below:We have found one hundred twenty available fundamental measures for In8bio, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to confirm all of In8bio latest market performance against the performance between 2010 and 2026 to make sure the company can sustain itself next year. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -27.4 M | -26 M | |
| Net Loss | -13.2 M | -13.8 M | |
| Net Loss | -27.4 M | -26 M | |
| Net Loss | (0.65) | (0.69) |
In8bio | Net Income | Build AI portfolio with In8bio Stock |
Analyzing In8bio's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing In8bio's current valuation and future prospects.
Latest In8bio's Net Income Growth Pattern
Below is the plot of the Net Income of In8bio Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in In8bio Inc financial statement analysis. It represents the amount of money remaining after all of In8bio Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is In8bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in In8bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (30.44 M) | 10 Years Trend |
|
Net Income |
| Timeline |
In8bio Net Income Regression Statistics
| Arithmetic Mean | (11,079,526) | |
| Coefficient Of Variation | (107.57) | |
| Mean Deviation | 10,524,092 | |
| Median | (2,081,000) | |
| Standard Deviation | 11,917,990 | |
| Sample Variance | 142T | |
| Range | 28.4M | |
| R-Value | (0.87) | |
| Mean Square Error | 38T | |
| R-Squared | 0.75 | |
| Slope | (2,043,045) | |
| Total Sum of Squares | 2272.6T |
In8bio Net Income History
Other Fundumenentals of In8bio Inc
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
In8bio Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for In8bio is extremely important. It helps to project a fair market value of In8bio Stock properly, considering its historical fundamentals such as Net Income. Since In8bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of In8bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of In8bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. Market participants price In8bio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive In8bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, In8bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
In8bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to In8bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of In8bio.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in In8bio on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding In8bio Inc or generate 0.0% return on investment in In8bio over 90 days. In8bio is related to or competes with Transcode Therapeutics, Aptevo Therapeutics, HCW Biologics, Lyra Therapeutics, Kiora Pharmaceuticals, Galecto, and Aprea Therapeutics. IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of ga... More
In8bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure In8bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess In8bio Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.03 | |||
| Information Ratio | 0.0294 | |||
| Maximum Drawdown | 37.96 | |||
| Value At Risk | (8.88) | |||
| Potential Upside | 14.29 |
In8bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for In8bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as In8bio's standard deviation. In reality, there are many statistical measures that can use In8bio historical prices to predict the future In8bio's volatility.| Risk Adjusted Performance | 0.0408 | |||
| Jensen Alpha | 0.1487 | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0404 | |||
| Treynor Ratio | 0.1379 |
In8bio February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0408 | |||
| Market Risk Adjusted Performance | 0.1479 | |||
| Mean Deviation | 4.88 | |||
| Semi Deviation | 4.8 | |||
| Downside Deviation | 5.03 | |||
| Coefficient Of Variation | 2525.59 | |||
| Standard Deviation | 6.89 | |||
| Variance | 47.51 | |||
| Information Ratio | 0.0294 | |||
| Jensen Alpha | 0.1487 | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0404 | |||
| Treynor Ratio | 0.1379 | |||
| Maximum Drawdown | 37.96 | |||
| Value At Risk | (8.88) | |||
| Potential Upside | 14.29 | |||
| Downside Variance | 25.26 | |||
| Semi Variance | 23.04 | |||
| Expected Short fall | (6.47) | |||
| Skewness | 1.45 | |||
| Kurtosis | 3.47 |
In8bio Inc Backtested Returns
In8bio appears to be extremely dangerous, given 3 months investment horizon. In8bio Inc retains Efficiency (Sharpe Ratio) of 0.0586, which attests that the entity had a 0.0586 % return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for In8bio, which you can use to evaluate the volatility of the firm. Please utilize In8bio's Semi Deviation of 4.8, market risk adjusted performance of 0.1479, and Standard Deviation of 6.89 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, In8bio holds a performance score of 4. The company owns a Beta (Systematic Risk) of 1.91, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, In8bio will likely underperform. Please check In8bio's mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to make a quick decision on whether In8bio's current price history will revert.
Auto-correlation | -0.18 |
Insignificant reverse predictability
In8bio Inc has insignificant reverse predictability. Overlapping area represents the amount of predictability between In8bio time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of In8bio Inc price movement. The serial correlation of -0.18 indicates that over 18.0% of current In8bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
In8bio Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, In8bio Inc reported net income of (30.44 Million). This is 108.92% lower than that of the Biotechnology sector and 143.45% lower than that of the Health Care industry. The net income for all United States stocks is 105.33% higher than that of the company.
In8bio Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses In8bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of In8bio could also be used in its relative valuation, which is a method of valuing In8bio by comparing valuation metrics of similar companies.In8bio is currently under evaluation in net income category among its peers.
In8bio Institutional Holders
Institutional Holdings refers to the ownership stake in In8bio that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of In8bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing In8bio's value.| Shares | Bank Of America Corp | 2025-06-30 | 24.0 | Goldman Sachs Group Inc | 2025-03-31 | 0.0 | 683 Capital Management Llc | 2025-03-31 | 0.0 | State Street Corp | 2025-06-30 | 0.0 | Susquehanna International Group, Llp | 2025-06-30 | 0.0 | Jane Street Group Llc | 2025-03-31 | 0.0 | Northern Trust Corp | 2025-06-30 | 0.0 | Sigma Planning Corp | 2025-06-30 | 0.0 | Citadel Advisors Llc | 2025-06-30 | 0.0 | Bios Capital Management, Lp | 2025-03-31 | 8.6 M | Franklin Resources Inc | 2025-06-30 | 189.9 K |
In8bio Fundamentals
| Return On Equity | -1.9 | ||||
| Return On Asset | -0.8 | ||||
| Current Valuation | 9.65 M | ||||
| Shares Outstanding | 9.77 M | ||||
| Shares Owned By Insiders | 23.04 % | ||||
| Shares Owned By Institutions | 65.75 % | ||||
| Number Of Shares Shorted | 133.5 K | ||||
| Price To Book | 1.32 X | ||||
| EBITDA | (26.94 M) | ||||
| Net Income | (30.44 M) | ||||
| Cash And Equivalents | 25.74 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 5.03 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.08 X | ||||
| Book Value Per Share | 2.87 X | ||||
| Cash Flow From Operations | (24.15 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (5.26) X | ||||
| Target Price | 12.5 | ||||
| Number Of Employees | 17 | ||||
| Beta | -0.01 | ||||
| Market Capitalization | 17.38 M | ||||
| Total Asset | 20.94 M | ||||
| Retained Earnings | (121.66 M) | ||||
| Working Capital | 9.49 M | ||||
| Net Asset | 20.94 M |
About In8bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze In8bio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:Check out You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. Market participants price In8bio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive In8bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, In8bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.